MCM
TDAC

Moore Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Moore Capital Management’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Hold
100,000
– – 0.02% 476
2026
Q1 		$1.06M Hold
100,000
– – 0.02% 355
2025
Q4 		$1.05M Hold
100,000
– – 0.02% 447
2025
Q3 		$1.03M Hold
100,000
– – 0.01% 416
2025
Q2 		$1.03M Buy
+100,000
New +$1.02M 0.01% 377

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.56% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

Moore Capital Management's TDAC Position: Q2 2026 in Review

Moore Capital Management held its Translational Development Acquisition Corp (TDAC) position steady in Q2 2026 at 100,000 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #476.

Moore Capital Management first reported a position in TDAC in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Moore Capital Management held 100,000 shares of Translational Development Acquisition Corp worth $1.07M as of Q2 2026.
  • Moore Capital Management left its Translational Development Acquisition Corp share count unchanged in Q2 2026.
  • Translational Development Acquisition Corp made up 0.02% of Moore Capital Management's portfolio in Q2 2026, its #476 holding.
  • Moore Capital Management first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.